miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2

MLA

Young-Hoon Han, et al. “MiR-29b Attenuates Tumorigenicity and Stemness Maintenance in Human Glioblastoma Multiforme by Directly Targeting BCL2L2.” Oncotarget, vol. 6, no. 21, Mar. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f02f3f02a7f95646129b5f11a638d9ab&authtype=sso&custid=ns315887.

APA

Young-Hoon Han, Myung-Jin Park, Hyun Joo Chung, In Hwa Bae, Eun Sook Kim, & Young Eun Choi. (2015). miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2. Oncotarget, 6(21).

Chicago

Young-Hoon Han, Myung-Jin Park, Hyun Joo Chung, In Hwa Bae, Eun Sook Kim, and Young Eun Choi. 2015. “MiR-29b Attenuates Tumorigenicity and Stemness Maintenance in Human Glioblastoma Multiforme by Directly Targeting BCL2L2.” Oncotarget 6 (21). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f02f3f02a7f95646129b5f11a638d9ab&authtype=sso&custid=ns315887.